Absence of influence of the ABO blood group system on hepatocellular carcinoma recurrence after living donor liver transplantation
نویسندگان
چکیده
Shin Hwang, Deok-Bog Moon, Gi-Won Song, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Ki-Hun Kim, Woo-Hyoung Kang, Young-In Yoon. Korean J Transplant 2022;36:32. https://doi.org/10.4285/ATW2022.F-1299
منابع مشابه
Peritoneal Recurrence of Initially Controlled Hepatocellular Carcinoma after Living Donor Liver Transplantation
It is well known that the presence of end-stage liver disease increases the risk of developing hepatocellular carcinoma (HCC). Liver transplantation (LT) for patients within the Milan criteria has become a standard treatment for HCC in most developed centers worldwide. However, a major cause of death in cirrhotic patients with HCC after transplantation is tumor recurrence, including peritoneal ...
متن کاملRecurrent hepatitis B following recurrence of hepatocellular carcinoma after living donor liver transplantation.
Hepatitis B virus (HBV) recurrence after liver transplantation for HBV-associated liver diseases results in decreased patient and graft survival. Herein we have reported two cases of HBV recurrence following relapse of hepatocellular carcinoma (HCC) after living donor liver transplantation (LDLT). Both cases had LDLT for end-stage liver disease secondary to HBV infection with nodules of HCC exc...
متن کاملDe-novo hepatocellular carcinoma after pediatric living donor liver transplantation
De-novo malignancies carry an incidence ranging between 3%-26% after transplant and account for the second highest cause of post-transplant mortality behind cardiovascular disease. While the majority of de-novo malignancies after transplant usually consist of skin cancers, there has been an increasing rate of solid tumor cancers over the last 15 years. Although, recurrence of hepatocellular car...
متن کاملRecurrence of hepatocellular carcinoma after liver transplantation.
Outcome after liver transplantation (OLT) clearly depends on recurrence of hepatocellular carcinoma (HCC). After recurrence, patient outcome will depend on the time and site of appearance. The aim of this study was to analyze the therapeutic implications of tumor recurrence behavior. From October 1988 to December 2005, 685 patients received OLT, including 202 due to HCC (32%). We analyzed 28 re...
متن کاملeffects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation
context hepatocellular carcinoma (hcc) is a fatal disease. chronic hepatitis b virus (hbv) and/or hepatitis c virus (hcv) infection is the major cause of hcc. high viral replication rate and related hepatic/systematic inflammation are the major risk factors in hcc recurrence after hepatectomy or liver transplantation. evidence acquisition some of the carcinogenesis-related hbv mutations are als...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean journal of transplantation
سال: 2022
ISSN: ['2671-8790', '2671-8804']
DOI: https://doi.org/10.4285/atw2022.f-1299